Komori
Yuki Gosei Kogyo (4531) · PolicyReframed

Enhancing Corporate Value through Fine-Chemicals-Based Manufacturing

First written in FY2022. 2 of 3 entries say "Reframed", first in FY2024. Latest entry: FY2026.

3entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022ReframedFY2024 – FY20262022: 120222023: 020232024: 120242025: 020252026: 12026
Same theme, other companies
Enhancing corporate value through fine-chemical-centered manufacturingA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「The Company formulated a three-year medium-term management plan beginning in the fiscal year ending March 2027. Under the basic policy of “Taking on the challenge of a new stage—sustainable growth through enhancement of corporate value,” we will address management challenges required to achieve new targets and further improve profitability.」

    The management philosophy of manufacturing centered on fine chemicals and enhancing corporate value over the medium to long term has been incorporated into the basic policy of the new medium-term plan as "Taking on the challenge of a new stage."
  2. FY2024ReframedAnnual report

    「"Key measures under the new medium-term management plan" ・Enhancement of corporate value」

    The longstanding management philosophy of enhancing and maximizing medium- to long-term corporate value through manufacturing centered on fine chemicals has been identified in the new medium-term plan as an independent key measure, "Enhancement of corporate value."
  3. FY2022First statedAnnual report

    「The company seeks to manage its business under the corporate philosophy, "We create products that are useful to people and bring them joy by drawing on every technology available, both inside and outside the company." To realize this philosophy, its management philosophy serves as a compass for responding flexibly to the needs of the times: "We will take on the challenge of true manufacturing by placing fine chemicals at the core and bringing together our wisdom and technology." The company considers its mission to be to sustain and grow its business activities soundly, and to continually enhance and maximize corporate value over the medium to long term for all stakeholders, including shareholders, customers, employees and local communities.」

    The company clearly states its corporate and management philosophies, identifying manufacturing centered on fine chemicals and the medium- to long-term enhancement of corporate value for all stakeholders as its management mission.
Moved together

"Establishing Pharmaceutical Intermediates and APIs as Growth Drivers" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222★123
  1. ★This thread
  2. 1Establishing Pharmaceutical Intermediates and APIs as Growth Drivers2×
  3. 2Revitalizing and Restructuring the Amino Acid Business to Maintain and Expand Global Market Leadership2×
  4. 3Risk of Breaching Financial Covenants on Syndicated Loans and Other Borrowings2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Yuki Gosei Kogyo's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Corporate Value through Fine-Chemicals-Based Manufacturing | Yuki Gosei Kogyo Co.,Ltd. (4531) | Komori